Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
Open accessThe DOI matches its Crossref record; 103 of the 106 references it cites were found in a registry or an index.
Abstract
Neurodegeneration elicits neuroinflammatory responses to kill pathogens, clear debris and support tissue repair. Neuroinflammation is a dynamic biological response characterized by the recruitment of innate and adaptive immune system cells in the site of tissue damage. Resident microglia and infiltrating immune cells partake in the restoration of central nervous system homeostasis. Nevertheless, their activation may shift to chronic and aggressive responses, which jeopardize neuron survival and may contribute to the disease process itself. Positron Emission Tomography (PET) molecular imaging represents a unique tool contributing to in vivo investigating of neuroinflammatory processes in patients. In the present review, we first provide an overview on the molecular basis of neuroinflammation in neurodegenerative diseases with emphasis on microglia activation, astrocytosis and the molecular targets for PET imaging. Then, we review the state-of-the-art of in vivo PET imaging for neuroinflammation in dementia conditions associated with different proteinopathies, such as Alzheimer’s disease, frontotemporal lobar degeneration and Parkinsonian spectrum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Methods to image microglia exist and are being used to test the effect of treatments on microglia205–210.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“The activation of microglia cells is a specific adapting reaction of the brain’s innate immune system, found in both physiological and pathological conditions [22].”
BackgroundNeuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 6×
“As for Aβ peptides deposition and neurofibrillary tangles formation, the key AD pathological hallmarks, neuroinflammation is now considered as a third component, which actively contributes to disease progression and chronic degeneration [25].”
BackgroundInfluentialFate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · cited 1×
“Microglia cells are tissue-resident mononuclear phagocytes of myeloid lineage, originating from erytromyeloid progenitors formed in the yolk sac, which makes them different from all the other central nervous system (CNS) macrophages formed in the bone marrow [17,18].”
BackgroundFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 7×
“While surveying, whenever microglia cells detect a noxa disturbing tissue homeostasis, they undergo a stepwise transformation towards an effector functional and morphological phenotype [20].”
BackgroundInfluentialTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“Based on solid preclinical and clinical data showing that immune system-mediated actions actively contribute to and drive AD pathogenesis [72], there was an increasing interest on the role of neuroinflammation within the pathological mechanisms occurring during the course of the disease [25].”
BackgroundMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · cited 2×
“This is especially true for the multiple functional phenotypes that microglia can adopt, which can dynamically switch in accordance with changes in the environment, thus delineating a very complex and dynamic system [9,24,28].”
BackgroundA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573 · cited 2×
“This is especially true for the multiple functional phenotypes that microglia can adopt, which can dynamically switch in accordance with changes in the environment, thus delineating a very complex and dynamic system [9,24,28].”
BackgroundMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 4×
“During activation, functional and morphological changes of microglia are coupled to the over-expression or de novo expression of several receptors [9].”
BackgroundInfluentialThe microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511 · cited 1×
“The microglia sensing apparatus, or sensome, involves a unique profile of gene expression, which changes with aging showing upregulation of genes controlling host defense and neuroprotection [23].”
BackgroundInnate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · cited 7×
“, interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) [3].”
BackgroundInfluentialMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 1×
“Microglia cells are tissue-resident mononuclear phagocytes of myeloid lineage, originating from erytromyeloid progenitors formed in the yolk sac, which makes them different from all the other central nervous system (CNS) macrophages formed in the bone marrow [17,18].”
BackgroundInflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
M1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,141
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 2×
“In vivo measurements of microglia activation with 11C-PK11195 PET imaging indeed showed increased regional tracer binding in the entorhinal, temporo-parietal, and cingulate cortex in AD and also in mild cognitive impairment (MCI) subjects [76], indicating that AD pathology could be associated with an early inflammator…”
BackgroundMethodInflammation after trauma: Microglial activation and traumatic brain injury
Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22455 · Cited by 999
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Regulation of innate immune responses in the brain
Rivest, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2565 · Cited by 843 · cited 1×
“The characteristics of the neuroinflammation response largely depend on the specific features of the trigger insult, including duration and magnitude, which can drive either a neuro-regenerative protective function or a neurotoxic action [7,8].”
BackgroundSpreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790 · cited 1×
“Neurodegenerative disorders are due to long-lasting pathological processes associated with the deposition of abnormal toxic proteins aggregates in the brain and the activation of a cascade of aberrant biochemical, metabolic, functional and structural changes [1,2].”
BackgroundOwen, D. R., Yeo, A. J., Gunn, R. N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D. J., Bennacef, I., Parker, C. A., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.147 · Cited by 779 · cited 2×
“These include: (i) the considerable amount of TSPO in the endothelium; (ii) the variability of plasma free fractions across human studies; and (iii) the presence of TSPO genetic polymorphism [61] that can alter radioligand binding [62].”
BackgroundAstrocytes: a central element in neurological diseases
Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J.-M., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755 · cited 2×
“Hypertrophic reactive astrogliosis is a complex, multistage and pathology-specific reaction, whose effects, comparable to microglia, highly vary in a context-specific manner from adaptive beneficial responses to maladaptive and deleterious processes [26].”
BackgroundHamelin, L., Lagarde, J., Dorothée, G., Leroy, C., Labit, M., Comley, R. A., de Souza, L. C., Corne, H., Dauphinot, L., Bertoux, M., et al. (2016) · Brain · doi:10.1093/brain/aww017 · Cited by 519 · cited 4×
“A recent large 18F-DPA714 PET study shows remarkable results in prodromal AD [53].”
BackgroundMethodInfluentialEdison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513 · cited 2×
“Some studies reported an inflammatory pattern mirroring the pattern of amyloid plaque deposition in both AD [78,79,84] and prodromal AD (i.”
BackgroundCosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459 · cited 1×
“The distribution of TSPO and MAO-B, however, is highly variable depending on disease, disease phase and proximity to the lesion [39,40].”
BackgroundCarter, S. F., Schöll, M., Almkvist, O., Wall, A., Engler, H., Långström, B., & Nordberg, A. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.087031 · Cited by 442 · cited 9×
“Several studies confirmed an increased 11C-PK11195 uptake in most AD patients and MCI subjects compared with controls in different neocortical regions, with the largest effect in the temporo-parietal cortex [66,77–84] (see Figure 1).”
BackgroundResultInfluentialNuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers
Chauveau, F., Boutin, H., Van Camp, N., Dollé, F., & Tavitian, B. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0908-9 · Cited by 417 · cited 4×
“At present, 11C-PK11195 remains thus the used and characterized TSPO ligand [41], with possible promising applications for the monitoring of anti-inflammatory therapies [60].”
BackgroundInfluentialRayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404
Venneti, S., Lopresti, B. J., & Wiley, C. A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.10.002 · Cited by 373
Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367
Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging
Lavisse, S., Guillermier, M., Hérard, A.-S., Petit, F., Delahaye, M., Van Camp, N., Ben Haim, L., Lebon, V., Remy, P., Dollé, F., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1487-12.2012 · Cited by 359 · cited 1×
“In response to injury, TSPO expression is markedly increased, mostly in reactive microglia and, to a lower extent, in astrocytes [38].”
BackgroundMixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands
Owen, D. R. J., Gunn, R. N., Rabiner, E. A., Bennacef, I., Fujita, M., Kreisl, W. C., Innis, R. B., Pike, V. W., Reynolds, R., Matthews, P. M., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.079459 · Cited by 358 · cited 2×
“Notably, TSPO genotype may considerably influence the second-generation radiotracer binding affinity [59], making genetic testing mandatory.”
BackgroundReference and target region modeling of [11C]-(R)-PK11195 brain studies.
Turkheimer, F., Edison, P., Pavese, N., Roncaroli, F., Anderson, A. N., Hammers, A., Gerhard, A., Hinz, R., Tai, Y., & Brooks, D. J. (2007) · Research Portal (King's College London) · Cited by 350
In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease
Kreisl, W. C., Lyoo, C. H., McGwier, M., Snow, J., Jenko, K. J., Kimura, N., Corona, W., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2013) · Brain · doi:10.1093/brain/awt145 · Cited by 350 · cited 10×
“Several studies confirmed an increased 11C-PK11195 uptake in most AD patients and MCI subjects compared with controls in different neocortical regions, with the largest effect in the temporo-parietal cortex [66,77–84] (see Figure 1).”
BackgroundInfluentialCzeh, M., Gressens, P., & Kaindl, A. M. (2011) · Developmental Neuroscience · doi:10.1159/000328989 · Cited by 321 · cited 1×
“The characteristics of the neuroinflammation response largely depend on the specific features of the trigger insult, including duration and magnitude, which can drive either a neuro-regenerative protective function or a neurotoxic action [7,8].”
BackgroundBrain connectivity in neurodegenerative diseases—from phenotype to proteinopathy
Pievani, M., Filippini, N., van den Heuvel, M. P., Cappa, S. F., & Frisoni, G. B. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.178 · Cited by 310 · cited 2×
“Emerging evidence suggests that neuroinflammation is a highly dynamic event with a potential pathogenetic role in neurodegenerative disorders [1].”
BackgroundPrimary Progressive Aphasia: Longitudinal Course, Neuropsychological Profile, and Language Features
Weintraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 310
Rodriguez-Vieitez, E., Saint-Aubert, L., Carter, S. F., Almkvist, O., Farid, K., Schöll, M., Chiotis, K., Thordardottir, S., Graff, C., Wall, A., et al. (2016) · Brain · doi:10.1093/brain/awv404 · Cited by 300 · cited 3×
“While 11C-DED uptake was significantly elevated only in the early presymptomatic stages in genetic AD cases, amyloid-β plaque deposition increased with disease progression [16].”
BackgroundInfluentialRole of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., & Zhang, H.-L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0245-0 · Cited by 262
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system
Rawji, K. S., Mishra, M. K., Michaels, N. J., Rivest, S., Stys, P. K., & Yong, V. W. (2016) · Brain · doi:10.1093/brain/awv395 · Cited by 252 · cited 1×
“Once populated, microglia self-sustain throughout adulthood [19].”
Noninvasive Molecular Imaging of Neuroinflammation
Jacobs, A. H., Tavitian, B., & the INMiND consortium (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.53 · Cited by 245 · cited 2×
“This property paved the way for the flourishing of PET-based molecular imaging techniques targeting neuroinflammation [33,34].”
BackgroundThe methodology of TSPO imaging with positron emission tomography
Turkheimer, F. E., Rizzo, G., Bloomfield, P. S., Howes, O., Zanotti-Fregonara, P., Bertoldo, A., & Veronese, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150058 · Cited by 238 · cited 6×
“TSPO PET techniques, irrespectively of the radioligand, share several caveats, which are intrinsically related to the target protein [62].”
BackgroundMethodInfluentialYasuno, F., Ota, M., Kosaka, J., Ito, H., Higuchi, M., Doronbekov, T. K., Nozaki, S., Fujimura, Y., Koeda, M., Asada, T., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.021 · Cited by 221 · cited 1×
“These new generation tracers include both carbon-11 and fluorine-18 radioligands, such as 11C-DPA713 [47], 11C-DAA1106 [48], 11C-PBR28 [49–51], 11C-vinpocetine [52], 18F-DPA714 [53], 18F-FEPPA [54], 18F-FEMPA [55] and 18F-FEDAA1106 [56–60], which have all been tested in a few human studies.”
BackgroundTREM2 and the neuroimmunology of Alzheimer's disease
Hickman, S. E., & El Khoury, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.021 · Cited by 221
Iannaccone, S., Cerami, C., Alessio, M., Garibotto, V., Panzacchi, A., Olivieri, S., Gelsomino, G., Moresco, R. M., & Perani, D. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.002 · Cited by 221 · cited 7×
“, substantia nigra and putamen) was reported in both PD and DLB cases [91].”
BackgroundInfluentialSelf-citationFan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K., Brooks, D. J., & Edison, P. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.016 · Cited by 212 · cited 3×
“Some studies reported an inflammatory pattern mirroring the pattern of amyloid plaque deposition in both AD [78,79,84] and prodromal AD (i.”
BackgroundThe 18 kDa Translocator Protein, Microglia and Neuroinflammation
Liu, G., Middleton, R. J., Hatty, C. R., Kam, W. W., Chan, R., Pham, T., Harrison‐Brown, M., Dodson, E., Veale, K., & Banati, R. B. (2014) · Brain Pathology · doi:10.1111/bpa.12196 · Cited by 211
Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
Vivash, L., & O’Brien, T. J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141713 · Cited by 190 · cited 2×
“Still, different from first- and second-generation carbon-11 ligands, only a few studies employing novel fluorine-18 radioligands are currently available in literature, urging for a thorough evaluation of these techniques in clinical practice [100].”
BackgroundMethodMolecular imaging of microglia/macrophages in the brain
Venneti, S., Lopresti, B. J., & Wiley, C. A. (2013) · Glia · doi:10.1002/glia.22357 · Cited by 189 · cited 2×
“This property paved the way for the flourishing of PET-based molecular imaging techniques targeting neuroinflammation [33,34].”
BackgroundDodel, R., Spottke, A., Gerhard, A., Reuss, A., Reinecker, S., Schimke, N., Trenkwalder, C., Sixel‐Döring, F., Herting, B., Kamm, C., et al. (2010) · Movement Disorders · doi:10.1002/mds.22732 · Cited by 187 · cited 3×
“Some studies focused on testing anti-inflammatory drugs in neurological disorders adopted TSPO-PET imaging to assess pre- and post-treatment changes in brain inflammatory patterns [60,98,99].”
BackgroundIn vivo detection of microglial activation in frontotemporal dementia
Cagnin, A., Rossor, M., Sampson, E. L., MacKinnon, T., & Banati, R. B. (2004) · Annals of Neurology · doi:10.1002/ana.20332 · Cited by 187 · cited 3×
“[87] reported a distribution pattern of microglia activation mirroring the pattern of neuronal metabolic dysfunction and clinical impairment in five patients fulfilling Neary criteria for FTD [90].”
BackgroundImaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET
Esposito, G., Giovacchini, G., Liow, J.-S., Bhattacharjee, A. K., Greenstein, D., Schapiro, M., Hallett, M., Herscovitch, P., Eckelman, W. C., Carson, R. E., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049619 · Cited by 183 · cited 1×
“A pilot PET study with 11C-radiolabeled AA showed in few AD patients a widely elevated tracer uptake in different neocortical regions [71].”
BackgroundBartels, A. L., Willemsen, A. T. M., Doorduin, J., de Vries, E. F. J., Dierckx, R. A., & Leenders, K. L. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.05.005 · Cited by 181
Venigalla, M., Sonego, S., Gyengesi, E., Sharman, M. J., & Münch, G. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.011 · Cited by 175
Yokokura, M., Mori, N., Yagi, S., Yoshikawa, E., Kikuchi, M., Yoshihara, Y., Wakuda, T., Sugihara, G., Takebayashi, K., Suda, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1612-0 · Cited by 174 · cited 3×
“Some studies reported an inflammatory pattern mirroring the pattern of amyloid plaque deposition in both AD [78,79,84] and prodromal AD (i.”
BackgroundMethod11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease
Kreisl, W. C., Lyoo, C. H., Liow, J.-S., Wei, M., Snow, J., Page, E., Jenko, K. J., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.011 · Cited by 174 · cited 12×
“Several studies confirmed an increased 11C-PK11195 uptake in most AD patients and MCI subjects compared with controls in different neocortical regions, with the largest effect in the temporo-parietal cortex [66,77–84] (see Figure 1).”
BackgroundInfluentialIn vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy
Gerhard, A., Trender‐Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P., & Brooks, D. J. (2006) · Movement Disorders · doi:10.1002/mds.20668 · Cited by 171 · cited 2×
“Namely, high 11C-PK11195 binding was found in the caudate, putamen, substantia nigra, and pons, pre- and postcentral gyri and in the frontal lobe in CBD patients [88] and in the basal ganglia, midbrain, frontal cortex and in the cerebellum in PSP patients [89].”
BackgroundResultMicroglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study
Schuitemaker, A., Kropholler, M. A., Boellaard, R., van der Flier, W. M., Kloet, R. W., van der Doef, T. F., Knol, D. L., Windhorst, A. D., Luurtsema, G., Barkhof, F., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.021 · Cited by 171 · cited 2×
“The results in MCI subjects, however, vary across studies, mostly depending on the method used for the quantification of the 11C-PK11195 uptake [76,83,84].”
BackgroundMethodWiley, C. A., Lopresti, B. J., Venneti, S., Price, J., Klunk, W. E., DeKosky, S. T., & Mathis, C. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.511 · Cited by 163 · cited 2×
“Notwithstanding some negative imaging, findings questioned the role of microgliosis as the inciting pathophysiologic factor in AD [52,58,64,74,75], and the majority of PET studies reveals significant activation of microglia in mild-moderate AD patients [10].”
BackgroundEvidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET
Johansson, A., Engler, H., Blomquist, G., Scott, B., Wall, A. E., Aquilonius, S., Långström, B., & Askmark, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.057 · Cited by 152
Versijpt, J. J., Dumont, F., van Laere, K. J., Decoo, D., Santens, P., Audenaert, K., Achten, E., Slegers, G., Dierckx, R. A., & Korf, J. (2003) · European Neurology · doi:10.1159/000070857 · Cited by 152
Yaqub, M., van Berckel, B. N., Schuitemaker, A., Hinz, R., Turkheimer, F. E., Tomasi, G., Lammertsma, A. A., & Boellaard, R. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.59 · Cited by 149 · cited 4×
“These algorithms thus deliver subject-specific pseudo-reference regions, which are groups of voxels sharing TACs typical of grey matter without specific binding [63,64].”
BackgroundMethodInfluentialYasuno, F., Kosaka, J., Ota, M., Higuchi, M., Ito, H., Fujimura, Y., Nozaki, S., Takahashi, S., Mizukami, K., Asada, T., et al. (2012) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.08.013 · Cited by 148
Genomics of Alzheimer Disease: A Review
Rosenberg, R. N., Lambracht-Washington, D., Yu, G., & Xia, W. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0301 · Cited by 146
In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration
Gerhard, A., Watts, J., Trender‐Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K., & Brooks, D. J. (2004) · Movement Disorders · doi:10.1002/mds.20162 · Cited by 144 · cited 1×
“Namely, high 11C-PK11195 binding was found in the caudate, putamen, substantia nigra, and pons, pre- and postcentral gyri and in the frontal lobe in CBD patients [88] and in the basal ganglia, midbrain, frontal cortex and in the cerebellum in PSP patients [89].”
BackgroundFan, Z., Okello, A. A., Brooks, D. J., & Edison, P. (2015) · Brain · doi:10.1093/brain/awv288 · Cited by 135
The Role of Neuroinflammation in Dementias
Pasqualetti, G., Brooks, D. J., & Edison, P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0531-7 · Cited by 133
Suridjan, I., Pollock, B. G., Verhoeff, N. P. L. G., Voineskos, A. N., Chow, T., Rusjan, P. M., Lobaugh, N. J., Houle, S., Mulsant, B. H., & Mizrahi, R. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.1 · Cited by 132 · cited 1×
“These new generation tracers include both carbon-11 and fluorine-18 radioligands, such as 11C-DPA713 [47], 11C-DAA1106 [48], 11C-PBR28 [49–51], 11C-vinpocetine [52], 18F-DPA714 [53], 18F-FEPPA [54], 18F-FEMPA [55] and 18F-FEDAA1106 [56–60], which have all been tested in a few human studies.”
Background(1995) · PubMed · Cited by 122
Imaging of neuroinflammation in dementia: a review
Stefaniak, J., & O'Brien, J. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311336 · Cited by 109 · cited 3×
“Notwithstanding some negative imaging, findings questioned the role of microgliosis as the inciting pathophysiologic factor in AD [52,58,64,74,75], and the majority of PET studies reveals significant activation of microglia in mild-moderate AD patients [10].”
BackgroundFujimura, Y., Ikoma, Y., Yasuno, F., Suhara, T., Ota, M., Matsumoto, R., Nozaki, S., Takano, A., Kosaka, J., Zhang, M., et al. (2006) · PubMed · Cited by 106
Patterns of microglial cell activation in frontotemporal lobar degeneration
Lant, S. B., Robinson, A. C., Thompson, J. C., Rollinson, S., Pickering‐Brown, S., Snowden, J. S., Davidson, Y. S., Gerhard, A., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12092 · Cited by 102 · cited 4×
“, GRN, C9ORF72) or non-genetic FTLD cases [12].”
BackgroundResultInfluentialMultitracer study with positron emission tomography in Creutzfeldt-Jakob disease
Engler, H., Lundberg, P. O., Ekbom, K., Nennesmo, I., Nilsson, A., Bergström, M., Tsukada, H., Hartvig, P., & Långström, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1008-x · Cited by 100
From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia
Tremblay, M.-È., Lecours, C., Samson, L., Sánchez-Zafra, V., & Sierra, A. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00045 · Cited by 97 · cited 1×
“In light of this evidence, some authors have referred to them as never-resting cells [21], implying that eventual morphological changes occurring in diseases should be considered as functional switches rather than activation states [20].”
BackgroundTomasi, G., Edison, P., Bertoldo, A., Roncaroli, F., Singh, P., Gerhard, A., Cobelli, C., Brooks, D. J., & Turkheimer, F. E. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.050583 · Cited by 97 · cited 1×
“Given the high TSPO binding in endothelium and at the blood–brain barrier (BBB) level, the integrity of which might be deranged in neurodegeneration, vasculature TSPO binding also needs to be accounted for to obtain an optimal specific binding estimation [62,65,66].”
BackgroundGulyás, B., Vas, Á., Tóth, M., Takano, A., Varrone, A., Cselényi, Z., Schain, M., Mattsson, P., & Halldin, C. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.020 · Cited by 94 · cited 2×
“These new generation tracers include both carbon-11 and fluorine-18 radioligands, such as 11C-DPA713 [47], 11C-DAA1106 [48], 11C-PBR28 [49–51], 11C-vinpocetine [52], 18F-DPA714 [53], 18F-FEPPA [54], 18F-FEMPA [55] and 18F-FEDAA1106 [56–60], which have all been tested in a few human studies.”
BackgroundSucksdorff, M., Rissanen, E., Tuisku, J., Nuutinen, S., Paavilainen, T., Rokka, J., Rinne, J., & Airas, L. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183020 · Cited by 93 · cited 1×
“Some studies focused on testing anti-inflammatory drugs in neurological disorders adopted TSPO-PET imaging to assess pre- and post-treatment changes in brain inflammatory patterns [60,98,99].”
BackgroundDecreased microglial activation in MS patients treated with glatiramer acetate
Ratchford, J. N., Endres, C. J., Hammoud, D. A., Pomper, M. G., Shiee, N., McGready, J., Pham, D. L., & Calabresi, P. A. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6337-x · Cited by 91 · cited 1×
“Some studies focused on testing anti-inflammatory drugs in neurological disorders adopted TSPO-PET imaging to assess pre- and post-treatment changes in brain inflammatory patterns [60,98,99].”
BackgroundDecreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
Ahmad, R. U., Postnov, A. A., Bormans, G. M., Versijpt, J. J., Vandenbulcke, M., & Laere, K. V. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3457-7 · Cited by 91 · cited 4×
“The authors thus argued for a possible lower affinity of the radioligand (11C-NE40) to CB2R [70].”
BackgroundResultInfluentialVarrone, A., Mattsson, P., Forsberg, A., Takano, A., Nag, S., Gulyás, B. Z., Borg, J., Boellaard, R., Al‐Tawil, N. G., Eriksdotter, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2359-1 · Cited by 90 · cited 1×
“Notwithstanding some negative imaging, findings questioned the role of microgliosis as the inciting pathophysiologic factor in AD [52,58,64,74,75], and the majority of PET studies reveals significant activation of microglia in mild-moderate AD patients [10].”
BackgroundThe Anti-Inflammatory Role of Minocycline in Alzheimers Disease
Budni, J., L. Garcez, M., de Medeiros, J., Cassaro, E., Bellettini-Santos, T., Mina, F., & Quevedo, J. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160819124206 · Cited by 90
Femminella, G. D., Ninan, S., Atkinson, R., Fan, Z., Brooks, D. J., & Edison, P. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150827 · Cited by 88 · cited 1×
“Accordingly, combined PET studies provided evidence for a significant inverse correlation between microglia activation and glucose metabolism in AD, MCI and PD dementia (PDD) patients [79] as well as with hippocampal volume in AD and PDD [80].”
BackgroundIn vivo imaging of astrocytosis in Alzheimer’s disease: an 11C-L-deuteriodeprenyl and PIB PET study
Santillo, A. F., Gambini, J. P., Lannfelt, L., Långström, B., Ulla-Marja, L., Kilander, L., & Engler, H. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1895-9 · Cited by 85 · cited 2×
“reported a regional correlation between 11C-DED and amyloid burden [13].”
BackgroundResultYokokura, M., Terada, T., Bunai, T., Nakaizumi, K., Takebayashi, K., Iwata, Y., Yoshikawa, E., Futatsubashi, M., Suzuki, K., Mori, N., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16646788 · Cited by 85 · cited 3×
“11C-PK11195) showed a greater sensitivity to TSPO activation for the second-generation tracer in both aging and AD patients [47].”
BackgroundVarley, J., Brooks, D. J., & Edison, P. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.08.105 · Cited by 82 · cited 3×
“Additional new targets for the in vivo detection of neuroinflammation in humans are currently under evaluation [42].”
BackgroundTranslational neuroimaging: positron emission tomography studies of monoamine oxidase
Fowler, J. S., Logan, J., Volkow, N. D., & Wang, G.-J. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0016-1 · Cited by 81 · cited 3×
“This molecule is an irreversible MAO-B inhibitor with high affinity and specificity for this enzyme, predominantly expressed on the outer mitochondrial membrane of astrocytes [39].”
BackgroundVarrone, A., Oikonen, V., Forsberg, A., Joutsa, J., Takano, A., Solin, O., Haaparanta-Solin, M., Nag, S., Nakao, R., Al-Tawil, N., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2955-8 · Cited by 79 · cited 1×
“These new generation tracers include both carbon-11 and fluorine-18 radioligands, such as 11C-DPA713 [47], 11C-DAA1106 [48], 11C-PBR28 [49–51], 11C-vinpocetine [52], 18F-DPA714 [53], 18F-FEPPA [54], 18F-FEMPA [55] and 18F-FEDAA1106 [56–60], which have all been tested in a few human studies.”
BackgroundMiyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.004 · Cited by 75 · cited 3×
“In the last years, some pilot PET studies investigated the microglia activation in vivo with PET imaging in frontotemporal lobar degeneration (FTLD) patients [87–89] as well as in presymptomatic FTLD mutated carriers [11,12].”
BackgroundZhou, X., Li, Y., Shi, X., & Ma, C. (2016) · PubMed Central · Cited by 75
TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?
Roncaroli, F., Su, Z., Herholz, K., Gerhard, A., & Turkheimer, F. E. (2016) · Clinical and Translational Imaging · doi:10.1007/s40336-016-0168-9 · Cited by 74
Kumlien, E., Nilsson, A., Hagberg, G., Långström, B., & Bergström, M. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.103006360.x · Cited by 70
Choo, I. H., Carter, S. F., Schöll, M. L., & Nordberg, A. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2859-7 · Cited by 61 · cited 2×
“This was not confirmed by following multitracer PET studies [14,15].”
BackgroundKropholler, M. A., Boellaard, R., van Berckel, B. N., Schuitemaker, A., Kloet, R. W., Lubberink, M. J., Jonker, C., Scheltens, P., & Lammertsma, A. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600488 · Cited by 56 · cited 1×
“Notwithstanding some negative imaging, findings questioned the role of microgliosis as the inciting pathophysiologic factor in AD [52,58,64,74,75], and the majority of PET studies reveals significant activation of microglia in mild-moderate AD patients [10].”
BackgroundKreisl, W. C., Lyoo, C. H., Liow, J.-S., Snow, J., Page, E., Jenko, K. J., Morse, C. L., Zoghbi, S. S., Pike, V. W., Turner, R. S., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.006 · Cited by 50 · cited 1×
“[49] showed greater 11C-PBR28 binding in posterior cortical atrophy-PCA in occipital, posterior parietal and temporal regions, notably with a close mirroring of the hypometabolic pattern revealed by 18F-FDG PET imaging [86].”
BackgroundAnderson, A. N., Pavese, N., Edison, P., Tai, Y., Hammers, A., Gerhard, A., Brooks, D. J., & Turkheimer, F. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.017 · Cited by 49 · cited 1×
“Given the high TSPO binding in endothelium and at the blood–brain barrier (BBB) level, the integrity of which might be deranged in neurodegeneration, vasculature TSPO binding also needs to be accounted for to obtain an optimal specific binding estimation [62,65,66].”
BackgroundBrain Changes within the Visuo-Spatial Attentional Network in Posterior Cortical Atrophy
Cerami, C., Crespi, C., Della Rosa, P. A., Dodich, A., Marcone, A., Magnani, G., Coppi, E., Falini, A., Cappa, S. F., & Perani, D. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-141275 · Cited by 47 · cited 1×
“[49] showed greater 11C-PBR28 binding in posterior cortical atrophy-PCA in occipital, posterior parietal and temporal regions, notably with a close mirroring of the hypometabolic pattern revealed by 18F-FDG PET imaging [86].”
BackgroundSelf-citationAiras, L. M., Rissanen, E., & Rinne, J. O. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516674568 · Cited by 38
Takano, A., Gulyás, B. Z., Varrone, A., Karlsson, P., Sjöholm, N., Larsson, S., Jonsson, C., Odh, R., Sparks, R. B., Tawil, N. A., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1864-3 · Cited by 35
Imaging Neuroinflammation in Ischemic Stroke and in the Atherosclerotic Vascular Disease
Cerami, C., & Perani, D. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113116660168 · Cited by 26
Self-citation
Cited by
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 366
“The same results have been obtained by positron emission tomographic (PET) analysis in living PD patients [28,29].”
BackgroundMicroglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365
Neuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
Werry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
“Whether neuroinflammation is a primary or secondary event and whether it has an overall beneficial or detrimental effect is hotly debated [3,27,28].”
Background
Metadata
- Authors
- Cerami, C., Iaccarino, L., & Perani, D.
- Affiliations
- IRCCS Ospedale San Raffaele (IT)
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Cerami, Chiara
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-05-05
- Volume
- 18
- Issue
- 5
- Pages
- 993
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5454906
- OpenAlex
- W2611177721
- Cited by
- 75
- References
- 106
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 3 · 2021: 11 · 2020: 10 · 2019: 22 · 2018: 6 · 2017: 8
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- Eli Lilly and Company
- Ministero dell’Istruzione, dell’Università e della Ricerca
- FP7 Health (278850)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- neuroinflammation, neurodegenerative dementia, positron emission tomography, microglial activation, astrocyte activation, Alzheimer's disease, frontotemporal lobar degeneration, proteinopathies, PET radiotracer, immune cell recruitment
- MeSH terms
- Alzheimer Disease, Humans, Inflammation, Microglia, Receptors, GABA, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.